Company Filing History:
5 out of 1,651 
1 out of 2,020 
Years Active: 2013-2025
Title: Mikhail Skliar: Innovator in Extracellular Vesicle Technology
Introduction
Mikhail Skliar is a prominent inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of biotechnology, particularly in the isolation and characterization of extracellular vesicles (EVs) and nanoparticles. With a total of 5 patents to his name, Skliar's work has the potential to advance various applications in medical and research settings.
Latest Patents
Mikhail Skliar's latest patents include innovative methods for the isolation, storage, and delivery of extracellular vesicles using asymmetric depth filters. This method allows for the high-yield and cost-effective isolation of EVs from biological fluids. The process involves passing the fluid through an asymmetric depth filter, where EVs become reversibly entrapped, enabling their release by simply reversing the flow. Another notable patent focuses on systems and methods for non-destructive isolation, concentration, and detection of nano- and bioparticles. This technology utilizes dielectrophoresis devices for the separation and characterization of analytes, offering real-time calculations of particle size and concentration.
Career Highlights
Throughout his career, Mikhail Skliar has worked with esteemed institutions such as the University of Utah Research Foundation and Arizona State University. His research has contributed to the understanding and application of EVs in various scientific fields.
Collaborations
Mikhail has collaborated with notable colleagues, including Kevin Whitty and Anthony Butterfield, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Mikhail Skliar's innovative work in the field of extracellular vesicle technology showcases his dedication to advancing scientific knowledge and applications. His patents reflect a commitment to developing efficient methods for isolating and characterizing nanoparticles, which could have far-reaching implications in biotechnology and medicine.